Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study
Women with nr-axSpA, but not r-axSpA, were less likely to achieve LDA and ID after 1 year than men. These data stress the need to carefully evaluate the diagnosis and causes of pain in patients diagnosed with axSpA.
Authors
- Servet Akar (ORCID: https://orcid.org/0000-0002-3734-1242)
- Hildrun Haibel (ORCID: https://orcid.org/0000-0002-5180-1831)
- Denis Poddubnyy (ORCID: https://orcid.org/0000-0002-4537-6015)
- Robert D. Inman (ORCID: https://orcid.org/0000-0002-4750-1422)
- Mikhail Protopopov (ORCID: https://orcid.org/0000-0003-4840-5069)
- Elisabeth Altmaier
- Santiago Muñoz‐Fernández (ORCID: https://orcid.org/0000-0002-2758-2085)
- Joachim Sieper (ORCID: https://orcid.org/0000-0003-0285-9890)
- Fabiana Ganz
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Izmir Kâtip Çelebi University (TR)
- AbbVie (United States) (US)
- Hospital Universitario Infanta Sofía (ES)
- IFT Institut für Therapieforschung (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1093/rheumatology/keaf447
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Swedish Orphan Biovitrum
- Samsung